Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer
Clinical trial NCT05035914 · UNKNOWN
Trial details
- NCT number
- NCT05035914
- Sponsor
- Guangzhou University of Traditional Chinese Medicine
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-09
- Primary completion
- 2022-12-31
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.